XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segments and Disaggregated Revenue (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segments and Disaggregated Revenue

 

 

Construction

 


Medical

Development



Corporate and support

 


Consolidated

 


Six Months Ended June 30, 2024





















Revenue 

$ 2,179,369

$

$ 91,978

$

$ 2,271,347

Cost of revenue



1,739,232











1,739,232

Operating expenses



91,814


85,960


3,496,628


3,683,979


7,358,381

Operating loss

348,323

(85,960 )

(3,404,650 )

(3,683,979 )

(6,826,266 )

Other income (expense)

(187,908 )




(1,631,814 )

(1,158,810 )

(2,978,532 )

Income (loss) before income taxes

160,415

(85,960 )

(5,036,464 )

(4,842,789 )

(9,804,798 )

Common stock deemed dividend










(670,881 )

(670,881 )

Net income attributable to non-controlling interest







1,946,822





1,946,822

Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 160,415
$ (85,960 )
$ (3,089,642 )
$ (5,513,670 )
$ (8,528,857 )























Total assets
$ 5,479,525

$ 1,406
$ 12,654,236
$ 2,793,342

$ 20,928,509

Depreciation and amortization
$
81,547

$

$

$ 3,487

$ 85,034

Capital expenditures
$ 7,873

$

$

$

$ 7,873


























Construction




Medical




Development



Corporate and support




Consolidated



Six Months Ended June 30, 2023

 



 







  





 






Revenue
$ 10,600,990

$

$

$

$ 10,600,990

Cost of revenue



10,636,832











10,636,832

Operating expenses



176,987


897


1,217,376


7,439,825


8,835,085

Operating income (loss)

(212,829 )

(897 )

(1,217,376 )

(7,439,825 )

(8,870,927 )

Other income (expense)

252,193



(475,046 )

18,816

(204,037 )

Income (loss) before income taxes

 


39,364



(897 )

(1,692,422

)

 

(7,421,009

)

 

(9,074,964 )

Net income attributable to non-controlling interest

 


 














Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 39,364
$ (897 )
$ (1,692,422 )
$ (7,421,009 )
$ (9,074,964 )























Total assets

$ 10,546,140

$ (897 )
$
(10,929,782 )
$
6,383,877

$
5,999,338

Depreciation and amortization
$ 710,578

$

$

$

$ 710,578

Capital expenditures
$

$

$

$

$

 


 

 

Construction

 


Medical

Development



Corporate and support

 


Consolidated

 


Three Months Ended June 30, 2024




















Revenue 

$ 1,211,254

$

$ 42,162

$

$ 1,253,416

Cost of revenue



1,094,249











1,094,249

Operating expenses



91,281


50,076


945,136


1,866,481


2,952,974

Operating income (loss)

25,724

(50,076)

(902,974 )

(1,866,481 )

(2,793,807 )

Other income (expense)

(137,955 )




(1,065,819 )

(550,189 )

(1,753,963 )

Income (loss) before income taxes

(112,231 )

(50,076)

(1,968,793 )

(2,416,670 )

(4,547,770 )

Common stock deemed dividend













Net income attributable to non-controlling interest







689,077





689,077

Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ (112,231 )
$ (50,076)
$ (1,279,716)
$ (2,416,670 )
$ (3,858,693 )























Total assets
$ 5,479,525

$ 1,406
$ 12,654,236
$ 2,793,342

$ 20,928,509

Depreciation and amortization
$
6,484

$

$

$ 1,807

$ 8,291

Capital expenditures
$

$

$

$

$


























Construction




Medical




Development



Corporate and support




Consolidated



Three Months Ended June 30, 2023 

 



 







  





 






Revenue
$ 5,097,055

$

$

$

$ 5,097,055

Cost of revenue



5,063,425











5,063,425

Operating expenses



58,428





496,463


5,089,597


5,644,488

Operating income (loss)

(24,798 )



(496,463 )

(5,089,597 )

(5,610,858 )

Other income (expense)

233,629



(187,749 )

9,454

55,334

Income (loss) before income taxes

 


208,831





(684,212

)

 

(5,080,143

)

 

(5,555,524 )

Net income attributable to non-controlling interest

 


 














Net income (loss) attributable to common stockholders of Safe & Green Holdings Corp.
$ 208,831
$
$ (684,212 )
$ (5,080,143 )
$ (5,555,524 )























Depreciation and amortization
$ 562,070

$

$

$

$ 562,070

Capital expenditures
$

$

$

$

$